loader image
Saturday, November 29, 2025
70.1 F
McAllen
- Advertisement -

Do People with Parkinson’s Always Develop Dementia?

Translate to Spanish or other 102 languages!

For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s. Image for illustration purposes
For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s. Image for illustration purposes
- Advertisement -
  • Dementia for people with Parkinson’s disease may occur less often, and when it does occur, may develop later, a new study suggests.
  • Two new investigations have found that early understanding of dementia’s inevitability for Parkinson’s patients has been significantly overstated.
  • One of the new investigations found that less than 10% of people with the disease had developed dementia 10 years after diagnosis.

For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s.

Follow the link below to Medical News Today of r the Full Story

https://www.medicalnewstoday.com/articles/parkinsons-disease-risk-developing-dementia-overstated

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×